PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC operating margin
Operating margin is operating income as a percentage of revenue.
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -769.0% | −627.4 |
| Q3 FY2024 | Sep 30, 2024 | -118.6% | +214.2 |
| Q2 FY2024 | Jun 30, 2024 | -232.6% | +360.0 |
| Q1 FY2024 | Mar 31, 2024 | -273.9% | – |
| Q3 FY2023 | Sep 30, 2023 | -141.6% | – |
| Q2 FY2023 | Jun 30, 2023 | -332.8% | – |
| Q1 FY2023 | Mar 31, 2023 | -592.6% | – |
See a number that looks wrong?